State of the Science Report for Perfluorooctane Sulfonate, Its Salts and Its Precursors that Contain the C₈F₁₇SO₂ or C₈F₁₇SO₃ Moiety

References

3M. 1999a. Perfluorooctane sulfonate: Current summary of human sera, health and toxicity data. 3M Company, January 21, 1999.

3M. 1999b. The science of organic fluorochemistry. 3M Company, February 5, 1999.

3M Environmental Laboratory. 2000. Determination of the presence and concentration of perfluorooctanesulfonate (PFOS) in liver and serum samples. # FACT TOX-030.

3M Environmental Laboratory. 2001. Determination of the presence and concentration of perfluorooctanesulfonate (PFOS) in liver and serum specimens of Crl:CD^®(SD) IGS BR rats exposed to perfluorooctane sulfonic acid potassium salt (PFOS T6295). # FACT TOX-002.

3M Medical Department. 2002. Identification of fluorochemicals in human sera. III. Pediatric participants in a group A streptococci clinical trial investigation. Medical Department, 3M Company. # EPI-0011.

Argus Research Laboratories, Inc. 1998. Oral (gavage) developmental toxicity study of N-EtFOSE in rats. # 418-011.

Argus Research Laboratories, Inc. 1999a. Combined oral (gavage) fertility, developmental and perinatal/postnatal reproduction toxicity study of PFOS in rats. # 418-008.

Argus Research Laboratories, Inc. 1999b. Combined oral (gavage) fertility, developmental and perinatal/postnatal reproduction toxicity study of N-EtFOSE in rats. # 418-009.

Argus Research Laboratories, Inc. 1999c. Oral (stomach tube) developmental toxicity study of N-EtFOSE in rabbits. # 418-010.

Argus Research Laboratories, Inc. 1999d. Final report: Oral (stomach tube) developmental toxicity study of PFOS in rabbits. # 418-012.

Argus Research Laboratories, Inc. 1999e. Oral (gavage) pharmacokinetic study of PFOS in rats. # 418-013.

Argus Research Laboratories, Inc. 1999f. Oral (gavage) pharmacokinetic study of PFOS in rats. # 418-015.

Argus Research Laboratories, Inc. 2000. Oral (gavage) cross-fostering study of PFOS in rats.

# 418-014.

Austin, M.E., Kasturi, B.S., Barber, M., Kannan, K., MohanKumar, P.S. and MohanKumar, S.M.J. 2003. Neuoroendocrine effects of perfluorooctane sulfonate in rats. Environ. Health Perspect. 111: 1485–1489.

Bio/Dynamics, Inc. 1979a. An acute inhalation toxicity study of T-2306 CoC in the rat. # 78-7185.

Bio/Dynamics, Inc. 1979b. An acute inhalation toxicity study of T-2307 CoC in the rat. # 78-7186.

Biosearch, Inc. 1978a. Acute oral toxicity — rats. # 77-1108A.

Biosearch, Inc. 1978b. Primary eye irritation study — rabbits. # 78-1161A.

Biosearch, Inc. 1978c. Acute oral toxicity — rats. # 77-1127A.

Biosearch, Inc. 1978d. Primary eye irritation study — rabbits. # 77-1127A.

Corning Hazleton, Inc. 1993. Mutagenicity test on T-5710 in an in vivo rat micronucleus assay. # 15516-0-454.

Corning Hazleton, Inc. 1996a. Mutagenicity test on T-6292 in an in vivo mouse micronucleus test. # 17384-0-455.

Corning Hazleton, Inc. 1996b. Mutagenicity test on T-6295 in an in vivo mouse micronucleus assay. # 17403-0-455.

Corning Hazleton, Inc. 1996c. Mutagenicity test on T-6294 in an in vivo mouse micronucleus assay. # 17385-0-455.

Corning Hazleton, Inc. 1997a. Acute oral toxicity study of T-6684 in rats. # CHW61101149.

Corning Hazleton, Inc. 1997b. Final report: Primary eye irritation/corrosion study of T-6684 in rabbits (OECD Guidelines). # 61101151.

Covance Laboratories, Inc. 1999a. Salmonella–Escherichia coli/mammalian-microsome reverse mutation assay with PFOS. # 20784-0-409.

Covance Laboratories, Inc. 1999b. Final report: Unscheduled DNA synthesis in rat liver primary cell cultures with PFOS. # 20784-0-447.

Covance Laboratories, Inc. 1999c. Chromosomal aberrations in human whole blood lymphocytes with PFOS. # 20784-0-449.

Covance Laboratories, Inc. 1999d. 13-week dietary toxicity study with T-6314 in rats. # 6329-225.

Covance Laboratories, Inc. 2000a. 4-week range-finding dietary toxicity study with N-methyl perfluorooctanesulfonamido ethanol (N-MeFOSE, T-6314) in rats. # 6329-224.

Covance Laboratories, Inc. 2000b. Final report. L5178Y TK⁺ mouse lymphoma forward mutation assay with a confirmatory assay with N-EtFOSE, T-6316. # 20785-0-431 ICH.

Covance Laboratories, Inc. 2001. Final report of the 104 week dietary carcinogenicity study with narrow range (98.1%) N-ethyl perfluorooctanesulfonamido-ethanol (N-EtFOSE) in rats. # 6329-212.

Covance Laboratories, Inc. 2002a. Final report: 104-week dietary chronic toxicity and carcinogenicity study with perfluorooctane sulfonic acid potassium salt (PFOS; T-6295) in rats. # 6329-183.

Covance Laboratories, Inc. 2002b. 26-week capsule toxicity study with perfluorooctane sulfonic acid potassium salt (PFOS T-6295) in cynomolgus monkeys. # 6329-223.

Environment Canada. 2001. Primary report on PFAs from Section 71 survey. Gatineau, Quebec.

Environment Canada. 2003. Technical working document for the environmental screening assessment of perfluorooctane sulfonate (PFOS) and its precursors. Existing Substances Branch, Gatineau, Quebec.

Hazleton Laboratories America, Inc. 1981. Corrected: Final report on acute inhalation toxicity study in rats. # 154-157.

Hazleton Laboratories America, Inc. 1983a. Pilot rat teratology study T-3352. Final report. # 154-159.

Hazleton Laboratories America, Inc. 1983b. Rat teratology study T-3351. # 154-160.

Hazleton Laboratories America, Inc. 1984. Rat teratology study T-3352. # 154-161.

Hazleton Laboratories America, Inc. 1985a. Final report: Acute oral toxicity: method, summary, pathology. # 50202473, sample T-3727.

Hazleton Laboratories America, Inc. 1985b. Final report: Acute oral toxicity: method, summary, pathology. # 50503499, sample T-3752.

Hazleton Laboratories America, Inc. 1985c. Final report, primary eye irritation — method, summary. # 50202473, sample T-3727.

Hazleton Laboratories America, Inc. 1985d. Final report primary eye irritation — method, summary. # 50503501, sample T-3752.

Hazleton Laboratories America, Inc. 1987a. Acute oral toxicity study in rats — method, summary, pathology, raw data appendix. # 70100353, sample T-4016.

Hazleton Laboratories America, Inc. 1987b. Primary eye irritation study in rabbits — method, summary, raw data appendix. # 70100355, sample T-4016.

Hazleton Laboratories America, Inc. 1988a. Acute oral toxicity study in rats (OECD Guidelines). # 70905392.

Hazleton Laboratories America, Inc. 1988b. Acute dermal toxicity study in rabbits (OECD Guidelines). # 70905393.

Hazleton Laboratories America, Inc. 1988c. Primary eye irritation/corrosion study in rabbits (OECD Guidelines). # 70905395.

Hazleton Washington, Inc. 1993a. Genotoxicity test on T-5710 in the in-vivo/in-vitro unscheduled DNA synthesis and cell proliferation in rat liver cells. # 15516-0-494.

Hazleton Washington, Inc. 1993b. Mutagenicity test on T-5711 in an in vivo rat micronucleus assay. # 15515-0-454.

Hazleton Washington, Inc. 1993c. Genotoxicity test on T-5711.1 (N-MeFOSE) in the in-vivo/in-vitro unscheduled DNA synthesis and cell proliferation in rat liver cells. # 15515-0-494.

Hazleton Wisconsin, Inc. 1991a. Acute oral toxicity study of T-5298 in rats (OECD Guidelines). # 01104196.

Hazleton Wisconsin, Inc. 1991b. Primary eye irritation/corrosion study of T-5298 in rabbits (OECD Guidelines). # 01104198.

Hazleton Wisconsin, Inc. 1994a. Acute oral toxicity study of PFOS T-5898 in rats. # 40200468.

Hazleton Wisconsin, Inc. 1994b. Final report: Primary eye irritation/corrosion study of PFOS (T-5898) in rabbits (OECD Guidelines). # 40200470.

Inoue, K., Okada, F., Ito, R., Kato, S., Sasaki, S., Nakajima, S., Uno, A., Saijo, Y., Sata, F., Yoshimura, Y., Kishi, R., and Nakazawa, H. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ. Health Perspec., 112: 1204-1207.

International Research and Development Corporation. 1978a. Fluorochemical FC-95, acute oral toxicity (LD₅₀) study in rats. # 137-083. 

International Research and Development Corporation. 1978b. FM-3422: Acute oral toxicity (LD₅₀) study in rats. # 137-084. 

International Research and Development Corporation. 1978c. Fluorochemical FC-95, ninety day subacute rat toxicity study. # 137-085.

International Research and Development Corporation. 1978d. Ninety day subacute rat toxicity study, FM-3422. # 137-086.

International Research and Development Corporation. 1978e. Fluorochemical FC-95, ninety day subacute rhesus monkey toxicity study. # 137-092.

International Research and Development Corporation. 1979. Ninety day subacute study in rhesus monkeys. # 137-088.

Kannan, K., Corsolini, S., Falandysz ,J., Fillmann, G., Kumar, K.S.,  Loganathan, B.G., Mohd, M.A., Olivero. J., Van Wouwe. N., Yang. J.H.,and  Aldoust, K.M.  2004. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol., 38:4489-95

Kubwabo, C., Vais, N. and Benoit, F. 2002. A pilot study on the determination of the level of perfluorooctanesulfonate and other organic fluorochemicals in human blood. Chemistry Research Division, Safe Environments Programme, Health Canada (unpublished).

Litton Bionetics, Inc. 1978. Mutagenicity evaluation of T-2014 CoC in the Ames Salmonella/microsome plate test. # 20838.

Mekenyan, O. and Dimitrov, S. 2002. PFOS metabolic pathways and metabolic distributions: Generated by catabolic simulator (2001–2002). Results compiled and edited by P. Robinson, Environment Canada, June 2002 [cited in Environment Canada, 2003].

NOTOX. 1994a. Evaluation of the mutagenic activity of T-5874 in the Ames Salmonella/microsome test (with independent repeat). # 115932.

NOTOX. 1994b. Evaluation of the mutagenic activity of T-5874 in an in vitro mammalian cell gene mutation test with L5178Y mouse lymphoma cells (with independent repeat). # 115921.

NOTOX. 1994c. Evaluation of the ability of T-5874 to induce chromosome aberrations in cultured peripheral human lymphocytes (with independent repeat). # 115919.

NOTOX. 1998. Evaluation of the mutagenic activity of T-6906 in an in vitro mammalian cell gene mutation test with L5178Y mouse lymphoma cells (with independent repeat). # 223458.

NOTOX. 1999. Exploratory 28-day oral toxicity study with telomer alcohol, telomer acrylate, [redacted confidential business information], PFHS and PFOS (positive control) by daily gavage in the rat followed by a 14/28-day recovery period. # 242933.

OECD (Organisation for Economic Co-operation and Development). 2002. Draft assessment of perfluorooctane sulfonate and its salts. Complete assessment. September 16, 2002.

Olsen, G.W., Hansen, K.J., Stevenson, L.A., Burris, J.M. and Mandel, J.H. 2003. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ. Sci. Technol. 37: 888–891.

Olsen, G.W., Huang, H-Y., Helzlsouer, K.J., Hansen, K.J., Butenhoff, J.L. and  Mandel, J.H. 2005. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate and other perfluorochemicals in human blood. Environ. Health  Perspec. 113: 539-545.

Riker Laboratories, Inc. 1979. Acute oral toxicity screen with T2574CoC in albino rats. # 097AR0037.

Riker Laboratories, Inc. 1980. Developmental studies in female rats exposed to FC-95. # 0680TR008.

Riker Laboratories, Inc. 1981a. Acute ocular irritation test with T-2997CoC in albino rabbits. # 0882EB0009.

Riker Laboratories, Inc. 1981b. Acute oral toxicity screen with T-3066CoC in albino rats. # 0981AR0146.

Riker Laboratories, Inc. 1981c. Acute oral toxicity screen with T-3065CoC in albino rats. # 0981AR0145.

Riker Laboratories, Inc. 1981d. Oral teratology study of FM-3422 in rats. # 0680TR0010.

Riker Laboratories, Inc. 1981e. Oral teratology study of T-2999CoC in rabbits. # 0681TB0212.

Riker Laboratories, Inc. 1983. Two year oral (diet) carcinogenicity study of fluorochemical FM-3924 in rats. # 0281CR0012.

Riker Laboratories, Inc. 1984. Acute ocular irritation test with T-3608 in albino rabbits. # 0984EB0367.

Riker Laboratories, Inc. 1987. Acute oral toxicity screen with T-3067CoC in albino rats. # 0981AR0147.

Seacat, A.M., Thomford, P.J., Hansen, K.J., Olsen, G.W., Case, M.T. and Butenhoff, J.L. 2002. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68: 249–264.

SRI International. 1978. In vitro microbiological mutagenicity assays of 3M Company compounds T-2247 CoC and T-2248 CoC. # LSC-4442-016.

SRI International. 1980. In vitro microbiological mutagenicity assays of 3M Company's compound T-2816CoC. # LSC-8958.

SRI International. 1981. In vitro microbiological mutagenicity assays of 3M Company's compound T-2997CoC. # LSC-8958

SRI International. 1982. In vitro microbiological mutagenicity assays of 3M Company's compound T-3209CoC. # LSC-3145.

SRI International. 1985. In vitro microbiological mutagenicity assays of 3M Company's compound T-3727 and T-3752. # LSC-3145.

Stump, D.G., Nemec, M.D., Holsom, J.F., Piccirillo, V.J. and Mare, J.T. 1997. Study of effects of sulfuramid on pre- and postnatal development, maturation and fertility in the rabbit. Toxicologist 36: 357.

Tittlemier, S.A., Ryan, J.J. and van Oostdam, J. 2004.  Presence of Anionic Perfluorinated Organic Compounds in Plasma Collected from Northern Canadian Populations.  Organohalogen Compounds, 64:4009-4014.

U.S. EPA (U.S. Environmental Protection Agency). 1989. Pesticides fact sheet. Office of Pesticides and Toxic Substances. OPTS # 205, 540/FS-89-060.

Warf Institute, Inc. 1974. Primary skin and primary eye irritation assessment of FC-95. #4102871.

Warf Institute, Inc. 1975. Dermal and ocular irritation of PFOS (T-1166) in rabbits. # 5011023.